Journal of Nutrition

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Nutrition Vol. 125 No. 11 November 1995, pp. 2763-2767
Copyright © 1995 by American Society for Nutrition
This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yu, S. G.
Right arrow Articles by Elson, C. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yu, S. G.
Right arrow Articles by Elson, C. E.

Geraniol, an Inhibitor of Mevalonate Biosynthesis, Suppresses the Growth of Hepatomas and Melanomas Transplanted to Rats and Mice1,2,

Suzanne G. Yu, Leslie A. Hildebrandt3 and Charles E. Elson4

Department of Nutritional Sciences, University of Wisconsin, Madison, Madison, WI 53706

Farnesyl-pyrophosphate is required for the posttranslational modification of G proteins including p21 rats, prelamin A and lamin B, each of which plays an essential role in cell proliferation. As a consequence, competitive inhibitors of mevalonate synthesis, the rate-limiting substrate for the synthesis of the prenyl-pyrophosphates, arrest cultured cells at the G1/S interface of the cell cycle and initiate apoptotic cell death. Geraniol, an acyclic monoterpenoid alcohol, suppresses 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase activity and concomitantly arrests the growth of cultured tumor cells. We evaluated the impact of dietary geraniol on the growth of two tumors. In the first study, geraniol (23 mmol/kg diet, 350 µmol/d) was fed to male buffalo rats for 14 d before and for 42 d after the transplant of Morris 7777 hepatomas. Tumor growth was suppressed (P < 0.001). In the second study, the dose-dependent impact of geraniol on the growth of B16 melanomas was assessed. Dietary geraniol (0.65, 6.5 and 65 mmol/kg diet) was fed to female C57BL mice for 14 d before and for 21 d after tumor transplant. Tumor growth was suppressed (P < 0.02) by 6.5 and 65 mmol geraniol/kg diet.


KEY WORDS: • mevalonate biosynthesis • tumor growth • rats • mice • chemoprevention

1 Supported by NIH grant CA 49416 and the College of Agricultural and Life Sciences, University of Wisconsin.

2 The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 USC section 1734 solely to indicate this fact.

3 Present address: Department of Food and Nutrition, Northern Arizona University, Flagstaff, AZ 86011.

4 To whom correspondence should be addressed.

Manuscript received 30 January 1995. Revision accepted 10 July 1995.




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
D. A. Wiseman, S. R. Werner, and P. L. Crowell
Cell Cycle Arrest by the Isoprenoids Perillyl Alcohol, Geraniol, and Farnesol Is Mediated by p21Cip1 and p27Kip1 in Human Pancreatic Adenocarcinoma Cells
J. Pharmacol. Exp. Ther., March 1, 2007; 320(3): 1163 - 1170.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
T. P. Ong, R. Heidor, A. de Conti, M. L. Z. Dagli, and F. S. Moreno
Farnesol and geraniol chemopreventive activities during the initial phases of hepatocarcinogenesis involve similar actions on cell proliferation and DNA damage, but distinct actions on apoptosis, plasma cholesterol and HMGCoA reductase
Carcinogenesis, June 1, 2006; 27(6): 1194 - 1203.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]